Trulieve Cannabis Corp.

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers on September 17, 1940 and is headquartered in Tallahassee, FL.

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

AdvisorShares MSOS 2x Daily ETF

Advisorshares Poseidon Dynamic Cannabis ETF

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Pelorus Equity Group's Rob Sechrist shares valuable advice for retail investors in the cannabis space. Scale is not the ultimate driver of cannabis companies.

Pragmatic Cannabis Investing

Trulieve Cannabis recorded $1.2 billion in revenue in 2022. It started as a small medical cannabis company, and now has 181 dispensaries.

3 Things About Trulieve Cannabis That Smart Investors Know

2 Marijuana Stocks To Buy And Hold In 2023? The post Cannabis Investing 2023 2 Marijuana Stocks To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Cannabis Investing 2023 2 Marijuana Stocks To Watch

Green Thumb Industries was more profitable in 2022 than Trulieve. Trulieve has more than twice as many dispensaries.

Better Buy: Green Thumb or Trulieve Stock?

Top Marijuana Stocks For Investing In Mid-March The post 2 Marijuana Stocks Top Buy This Monday 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks Top Buy This Monday 2023

Innovative Industrial Properties

Jazz Pharmaceuticals

Village Farms International

Get in the know about medical marijuana stocks.

Best Medical Marijuana Stocks to Buy

The cannabis industry has experienced a number of serious challenges that have some investors questioning its future. These challenges are adversely affecting leading cannabis company Trulieve.

Trulieve Is Navigating The Turbulent Currents Of Cannabis With Confidence

Trulieve Cannabis Corp. (CSE:TRUL) has held onto its ‘Buy' ratings from analysts at Canaccord Genuity and Stifel GMP although both brokerages have reduced their price targets after the medical cannabis company produced fourth-quarter 2022 results and provided 2023 guidance that were below expectations.  Canaccord's analysts said revenue of $302 million came in below its $311 million estimate and consensus of $306 million.

Trulieve Cannabis retains ‘Buy' rating with reduced price target from Canaccord and Stifel following softer-than-expected 4Q earnings

Trulieve Cannabis Corp. is more bullish on prospects for a ballot referendum to approve adult-use cannabis in its home state of Florida which may be a potential spark for its stock.

Trulieve warns of revenue dip, but sees potential 2024 adult use pot ballot in Florida

Trulieve Cannabis Corp. (OTCQX:TCNNF) Q4 2022 Results Conference Call March 8, 2023 8:30 AM ET Company Participants Christine Hersey - Vice President, Investor Relations Kim Rivers - Chief Executive Officer Alex D'Amico - Chief Financial Officer Steve White - President Conference Call Participants Matt McGinley - Needham Russell Stanley - Beacon Securities Kenric Tyghe - ATB Capital Market Aaron Grey - Alliance Global Partners Derek Dley - Canaccord Genuity Pablo Zuanic - Cantor Fitzgerald Andrew Partheniou - Stifel Eric Des Lauriers - Craig-Hallum Capital Group Ty Collin - Eight Capital Andrew Semple - Echelon Capital Markets Operator Good evening, everyone and welcome to the Trulieve Cannabis Corporation Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Betsy and I will be your conference operator today.

Trulieve Cannabis Corp. (TCNNF) Q4 2022 Earnings Call Transcript

New dispensary expands patient access to medical cannabis; grand opening specials available TALLAHASSEE, Fla. , March 8, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary in Palatka, Florida.

Trulieve Opening Medical Marijuana Dispensary in Palatka, FL

Trulieve Cannabis Corp. TRUL, -0.22% TCNNF, -0.30% said Wednesday it had a net loss of $77 million, or 40 cents a share, in the fourth quarter, wider than the loss of $72 million, or 48 cents a share, posted in the year-earlier period. Excluding one-time items, its adjusted loss per share came to 18 cents, wider than the 8 cent FactSet consensus.

Trulieve posts wider-than-expected fourth-quarter loss as revenue comes up short

Record revenue of $1.24 billion in 2022, up 32% year over year, and quarterly revenue of $302 million, with 2% retail revenue growth sequentially Industry leading U.S. retail network of 181 dispensaries, up 14% from 2021, supported by over 4 million square feet of cultivation and processing capacity as of December 31, 2022 Achieved fourth quarter operating cash flow of $55 million and free cash flow of $21 million TALLAHASSEE, Fla. , March 8, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the fourth quarter and full year ended December 31, 2022.

Trulieve Reports Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue

The Best Marijuana Stocks For Cannabis Investing 2023 The post 3 Marijuana Stocks To Keep On Your 2023 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Keep On Your 2023 Watchlist

Grand opening celebration event on March 3 TALLAHASSEE, Fla. , March 3, 2023 /PRNewswire/ --  Trulieve Cannabis Corp.  (CSE:  TRUL ) (OTCQX:  TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of its Beckley, West Virginia dispensary on March 3.

Trulieve Opens New Medical Cannabis Dispensary in Beckley, West Virginia

Tilray Brands

The first ever cannabis investing podcast roundtable discussion! Investing in the cannabis industry: stocks, ETFs and patience.

Cannabis Investing Podcast Roundtable (Transcript)

Marijuana Stocks To Invest In This Year The post 3 Marijuana Stocks To Watch In Stock Market Today 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch In Stock Market Today 2023

I have followed Trulieve since it went public in 2018. The company has evolved from solely a Florida operator to one that is a big player in a few markets.

Troubled Trulieve Is A Timely Buy

2 Top Marijuana Stocks To Buy This March? The post 2 Marijuana Stocks To Watch During March 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Watch During March 2023

TALLAHASSEE, Fla. , Feb. 24, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it will reschedule the release of financial results and earnings call for the fourth quarter and full year 2022.

Trulieve Cannabis Corp. to Reschedule Fourth Quarter and Full Year 2022 Results Conference Call to March 8, 2023

MedMen Enterprises Inc.

A prolonged downturn and liquidity crunch have led to more consolidation across the sector. Some are strong, some are surviving.

Cannabis Consolidation Continues

Best Cannabis Stocks To Right Now? The post Are US Marijuana Stocks A Buy Before March? 3 For Your List This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are US Marijuana Stocks A Buy Before March? 3 For Your List This Week

Trulieve is one of the more profitable operators in US cannabis. The company has 50% market share in Florida and is positioned to benefit from potential legalization in Pennsylvania and other states.

Cannabis Stocks Have Crashed: Trulieve Is A Gem In U.S. Cannabis

These multistate operators already hold strong positions in the state's medical marijuana market.

2 Cannabis Companies Poised to Benefit If West Virginia Legalizes Recreational Pot Use

2 Marijuana Stocks To Buy In Todays Market The post 2 Marijuana Stocks To Watch Next Week 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

News for Trulieve Cannabis Corp. Stock (TCNNF)